Presbyopia News

When Bette Davis said, “Old age ain’t for sissies,” she might have been referring to the challenge of correcting presbyopia.

Few conditions impact as many people worldwide as presbyopia. Recent estimates have placed the prevalence of presbyopia in the 2 billion range.

Presbyopia is the second most common refractive error in the United States, with about 128 million of 335 million Americans, or 38% of the population, being presbyopic. Myopia today is slightly higher at 42% of the population.

When patients come to my office for comprehensive eye exams, common questions, especially for those who are in the early stages of presbyopia, include, “Why am I losing vision?” and, more importantly, “How can this be treated?”

KOLOA, Hawaii — Ophthalmologists must embrace corneal diagnostics to select the proper patient for premium multifocal IOLs, according to a presenter at Hawaiian Eye 2025.

KOLOA, Hawaii — With appropriate IOL selection, careful preoperative assessment and accurate calculations, presbyopia-correcting IOLs can be successful in patients who previously underwent corneal refractive surgery, according to a speaker.

Occasionally, treatments come along that are of greater interest to patients than to doctors.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Jason Bacharach, MD, of North Bay Eye Associates, shares data on an aceclidine-based presbyopia-correcting eye drop from Lenz Therapeutics.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Paul Smith of Orasis Pharmaceuticals discusses the benefits that Qlosi provides patients with presbyopia.